As of 2026-09-27, the Intrinsic Value of Edgewise Therapeutics Inc (EWTX) is -9.17 USD. This EWTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 39.34 USD, the upside of Edgewise Therapeutics Inc is -123.30%.
Based on its market price of 39.34 USD and our intrinsic valuation, Edgewise Therapeutics Inc (EWTX) is overvalued by 123.30%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.17 - -9.17 | -9.17 | -123.30% |
| P/E | (37.98) - (40.77) | (48.39) | -223.0% |
| DDM - Stable | (22.25) - (165.08) | (93.67) | -338.1% |
| DDM - Multi | (18.13) - (106.07) | (31.11) | -179.1% |
| Market Cap (mil) | 4,232.59 |
| Beta | 1.03 |
| Outstanding shares (mil) | 107.59 |
| Enterprise Value (mil) | 4,160.27 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.38% |
| Cost of Debt | 5.00% |
| WACC | 5.64% |